Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Chirurgia (Bucharest, Romania : 1990)|December 30, 2021
Systemic Treatment of Ductal Carcinoma In Situ of the BreastEdoardo Crimini, Chiara Corti, Matteo Repetto, et al.
Cancers|January 23, 2024
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor TargetingEdoardo Crimini, Luca Boscolo Bielo, Pier Paolo Maria Berton Giachetti, et al.
The Oncologist|March 23, 2024
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of OncologyLuca Boscolo Bielo, Carmen Belli, Edoardo Crimini, et al.
Expert Opinion on Pharmacotherapy|May 22, 2026
Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title: oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancerJulian David Etessami, Carmine Valenza, Pier Paolo Maria Berton Giachetti, et al.
The Oncologist|May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysisLuca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
Vaccines|February 26, 2026
Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future DirectionsJorge Iranzo, Edoardo Giordano, Renato Maria Marsicano, et al.
The Oncologist|June 1, 2024
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancersCarmen Belli, Luca Boscolo Bielo, Matteo Repetto, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 2023
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experienceMatteo Repetto, Edoardo Crimini, Luca Boscolo Bielo, et al.
The Oncologist|September 5, 2023
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National ExperienceEdoardo Crimini, Giulia Tini, Paolo Tarantino, et al.
Cancers|November 27, 2021
Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical TrialsPamela Trillo Aliaga, Dario Trapani, José Luis Sandoval, et al.
Pageof 4